These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26803410)

  • 1. Fibrin matrices enhance the transplant and efficacy of cytotoxic stem cell therapy for post-surgical cancer.
    Bagó JR; Pegna GJ; Okolie O; Hingtgen SD
    Biomaterials; 2016 Apr; 84():42-53. PubMed ID: 26803410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma.
    Bagó JR; Pegna GJ; Okolie O; Mohiti-Asli M; Loboa EG; Hingtgen SD
    Biomaterials; 2016 Jun; 90():116-25. PubMed ID: 27016620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing Implantable Scaffolds to Enhance Neural Stem Cell Therapy for Post-Operative Glioblastoma.
    Sheets KT; Ewend MG; Mohiti-Asli M; Tuin SA; Loboa EG; Aboody KS; Hingtgen SD
    Mol Ther; 2020 Apr; 28(4):1056-1067. PubMed ID: 32109370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.
    Bagó JR; Okolie O; Dumitru R; Ewend MG; Parker JS; Werff RV; Underhill TM; Schmid RS; Miller CR; Hingtgen SD
    Sci Transl Med; 2017 Feb; 9(375):. PubMed ID: 28148846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas.
    Kauer TM; Figueiredo JL; Hingtgen S; Shah K
    Nat Neurosci; 2011 Dec; 15(2):197-204. PubMed ID: 22197831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of Cytotoxic Mesenchymal Stem Cells with Biodegradable Scaffolds for Treatment of Postoperative Brain Cancer.
    Sheets KT; Bagó JR; Hingtgen SD
    Methods Mol Biol; 2018; 1831():49-58. PubMed ID: 30051424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection.
    Okolie O; Irvin DM; Bago JR; Sheets K; Satterlee A; Carey-Ewend AG; Lettry V; Dumitru R; Elton S; Ewend MG; Miller CR; Hingtgen SD
    PLoS One; 2018; 13(7):e0198596. PubMed ID: 29990322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors.
    Redjal N; Zhu Y; Shah K
    Stem Cells; 2015 Jan; 33(1):101-10. PubMed ID: 25186100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of composite scaffold degradation rate on neural stem cell persistence in the glioblastoma surgical resection cavity.
    Moore KM; Graham-Gurysh EG; Bomba HN; Murthy AB; Bachelder EM; Hingtgen SD; Ainslie KM
    Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110846. PubMed ID: 32279815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds.
    Sheets KT; Bagó JR; Paulk IL; Hingtgen SD
    J Vis Exp; 2018 Jul; (137):. PubMed ID: 30059037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing Bioinspired Three-Dimensional Models of Brain Cancer to Evaluate Tumor-Homing Neural Stem Cell Therapy.
    Carey-Ewend AG; Hagler SB; Bomba HN; Goetz MJ; Bago JR; Hingtgen SD
    Tissue Eng Part A; 2021 Jul; 27(13-14):857-866. PubMed ID: 32907497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts.
    Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; Coccè V; Bonomi A; Buccarelli M; Pascucci L; Alessandri G; Pessina A; Ricci-Vitiani L; Falchetti ML; Pallini R
    Stem Cell Res Ther; 2017 Mar; 8(1):53. PubMed ID: 28279193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
    Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
    Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels.
    Wang C; Tong X; Yang F
    Mol Pharm; 2014 Jul; 11(7):2115-25. PubMed ID: 24712441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma.
    Satterlee AB; Dunn DE; Lo DC; Khagi S; Hingtgen S
    Neuro Oncol; 2019 Dec; 21(12):1552-1564. PubMed ID: 31420675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.
    Graham-Gurysh E; Moore KM; Satterlee AB; Sheets KT; Lin FC; Bachelder EM; Miller CR; Hingtgen SD; Ainslie KM
    Mol Pharm; 2018 Mar; 15(3):1309-1318. PubMed ID: 29342360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and Profiling of Tumor-Homing Induced Neural Stem Cells from the Skin of Cancer Patients.
    Buckley A; Hagler SB; Lettry V; Bagó JR; Maingi SM; Khagi S; Ewend MG; Miller CR; Hingtgen SD
    Mol Ther; 2020 Jul; 28(7):1614-1627. PubMed ID: 32402245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric Biomaterial Scaffolds for Tumoricidal Stem Cell Glioblastoma Therapy.
    Moore KM; Murthy AB; Graham-Gurysh EG; Hingtgen SD; Bachelder EM; Ainslie KM
    ACS Biomater Sci Eng; 2020 Jul; 6(7):3762-3777. PubMed ID: 33463324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence.
    Oudin A; Moreno-Sanchez PM; Baus V; Niclou SP; Golebiewska A
    BMC Cancer; 2024 Jan; 24(1):3. PubMed ID: 38166949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of an imageable surgical resection animal model of Glioblastoma (GBM).
    Sweeney KJ; Jarzabek MA; Dicker P; O'Brien DF; Callanan JJ; Byrne AT; Prehn JH
    J Neurosci Methods; 2014 Aug; 233():99-104. PubMed ID: 24952322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.